LB PHARMACEUTICALS INC - 8-K Filing
LB Pharmaceuticals appoints Susan G. Kozauer, M.D., as Chief Medical Officer effective September 14, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $LBRX